IBDEI0LJ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10209,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,10209,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,10209,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,10210,0)
 ;;=379.91^^44^562^87
 ;;^UTILITY(U,$J,358.3,10210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10210,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,10210,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,10210,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,10211,0)
 ;;=V58.69^^44^562^44
 ;;^UTILITY(U,$J,358.3,10211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10211,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,10211,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,10211,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,10212,0)
 ;;=871.4^^44^562^54
 ;;^UTILITY(U,$J,358.3,10212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10212,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,10212,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,10212,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,10213,0)
 ;;=242.90^^44^562^108
 ;;^UTILITY(U,$J,358.3,10213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10213,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,10213,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,10213,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,10214,0)
 ;;=135.^^44^562^101
 ;;^UTILITY(U,$J,358.3,10214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10214,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,10214,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,10214,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,10215,0)
 ;;=446.5^^44^562^107
 ;;^UTILITY(U,$J,358.3,10215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10215,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,10215,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,10215,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,10216,0)
 ;;=401.9^^44^562^49
 ;;^UTILITY(U,$J,358.3,10216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10216,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,10216,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,10216,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,10217,0)
 ;;=V72.0^^44^562^32
 ;;^UTILITY(U,$J,358.3,10217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10217,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,10217,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,10217,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,10218,0)
 ;;=V41.0^^44^562^91
 ;;^UTILITY(U,$J,358.3,10218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10218,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,10218,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,10218,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,10219,0)
 ;;=998.59^^44^562^89
 ;;^UTILITY(U,$J,358.3,10219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10219,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,10219,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,10219,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,10220,0)
 ;;=042.^^44^562^1
 ;;^UTILITY(U,$J,358.3,10220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10220,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,10220,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,10220,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,10221,0)
 ;;=053.29^^44^562^43
 ;;^UTILITY(U,$J,358.3,10221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10221,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,10221,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,10221,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,10222,0)
 ;;=054.40^^44^562^42
 ;;^UTILITY(U,$J,358.3,10222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10222,1,3,0)
 ;;=3^Herpes Simplex
 ;;
 ;;$END ROU IBDEI0LJ
